FAM83A exerts tumor‑suppressive roles in cervical cancer by regulating integrins

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Family with sequence similarity 83 member A (FAM83A) is often upregulated in cancers, leading to its hypothesis as an oncogene.
• The precise role of FAM83A in cervical cancer remains largely undetermined.
• Understanding FAM83A's function is crucial for developing targeted cervical cancer therapies.

Purpose of the Study:

• To investigate the functional role of FAM83A in cervical cancer.
• To elucidate the molecular mechanisms underlying FAM83A's action in cervical cancer.
• To assess the prognostic significance of FAM83A in cervical cancer patients.

Main Methods:

• Analysis of FAM83A expression in normal and cervical cancer tissues.
• FAM83A knockdown in CaSki and HeLa cell lines.
• In vivo studies using a mouse xenograft model.
• RNA sequencing to identify affected pathways.
• Western blot analysis to assess integrin protein levels.

Main Results:

• FAM83A expression was decreased in advanced cervical cancer stages and associated with poorer patient survival.
• FAM83A knockdown enhanced cell proliferation, migration, and invasion, and promoted tumor growth in vivo.
• Knockdown of FAM83A led to increased transcription of oncogenesis-associated genes and elevated protein levels of specific integrins (α1, α3, α5, β4, β5).
• FAM83A expression inversely correlated with integrin levels in patient tissues.

Conclusions:

• FAM83A appears to function as a tumor suppressor in cervical cancer, contrary to its oncogenic role in other cancers.
• FAM83A may exert its tumor-suppressive effects by inhibiting integrin expression.
• These findings offer novel insights into cervical cancer biology and suggest FAM83A as a potential therapeutic target.